U.S. flag

An official website of the United States government

Format
Items per page
Sort by

Send to:

Choose Destination

Links from GEO DataSets

Items: 20

1.
Full record GDS3973

Docetaxel resistant prostate cancer cell line

Analysis of prostate cancer cell lines resistant to docetaxel chemotherapy, DU-145R and PC-3R, which were derived from cell lines DU-145 and PC-3, respectively. Results provide insight into the molecular mechanisms underlying docetaxel resistance.
Organism:
Homo sapiens
Type:
Expression profiling by array, transformed count, 4 cell line sets
Platform:
GPL570
Series:
GSE33455
12 Samples
Download data: CEL
DataSet
Accession:
GDS3973
ID:
3973
2.

Expression data from docetaxel-resistant prostate cancer cell lines

(Submitter supplied) Docetaxel-based chemotherapy is the standard first-line therapy in metastatic castration-resistant prostate cancer. However, most patients eventually develop resistance to this treatment. The aim of the study was to identify key molecular genes and networks associated with docetaxel resistance in 2 models of docetaxel-resistant castration-resistant prostate cancer cell lines.
Organism:
Homo sapiens
Type:
Expression profiling by array
Dataset:
GDS3973
Platform:
GPL570
12 Samples
Download data: CEL
Series
Accession:
GSE33455
ID:
200033455
3.

Expression data from prostate cancer cell lines C4-2B (docetaxel sensitive) and TaxR (docetaxel resistant) cells

(Submitter supplied) Prostate cancer C4-2B cells were cultured in docetaxel in a dose-escalation manner. After nine months selection, cells were able to divide freely in 5 nM docetaxel, with a specific sets of genes been deregulated. We performed global gene expression analysis by cDNA microarrays to identify genes responsible for docetaxel resistance in TaxR cells.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL6244
2 Samples
Download data: CEL
Series
Accession:
GSE47040
ID:
200047040
4.

Cytotoxic activity of HTI-286 in prostate cancer

(Submitter supplied) HTI-286, an analogue of hemiasterlin, interferes with microtubule dynamics and circumvents transport-based resistance to taxanes. In this study we evaluate the inhibitory effects of HTI-286 on human prostate cancer growth in vitro and in different in vivo models. The results show that HTI-286 is a potent inhibitor of proliferation and induced marked increases in apoptotic rates in all cell lines tested. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Dataset:
GDS2971
Platform:
GPL3877
12 Samples
Download data
Series
Accession:
GSE8325
ID:
200008325
5.
Full record GDS2971

Hemiasterlin analog HTI-286 effect on docetaxel-resistant prostate cancer cell line

Analysis of prostate cancer LNCaP cells treated with the chemotherapeutic agent docetaxel or the hemiasterlin analog HTI-286. Like docetaxel, HTI-286 disrupts microtubule dynamics. But unlike docetaxel, HT-286 exhibits reduced multidrug resistance.
Organism:
Homo sapiens
Type:
Expression profiling by array, log2 ratio, 2 agent sets
Platform:
GPL3877
Series:
GSE8325
12 Samples
Download data
DataSet
Accession:
GDS2971
ID:
2971
6.

Analysis of cabazitaxel-resistant mechanism in human castration-resistant prostate cancer

(Submitter supplied) To investigate cabazitaxel (CBZ) resistance in prostate cancer, we examined the changes in global gene expression before and after development of acquired CBZ resistance. Functional annotation clustering (FAC) analysis of DAVID showed cell division (GO: 0051301) and mitotic nuclear division (GO: 0007067) were the most enhanced clusters in DU145CR compared with DU145.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL16686
2 Samples
Download data: CEL, CHP
Series
Accession:
GSE110107
ID:
200110107
7.

Altered expression of long noncoding RNAs in LNCaP castration resistant prostate cancer cell lines

(Submitter supplied) Castration-resistant prostate cancer (CRPC) that arise after the failure of androgen deprivation therapy is a leading cause of deaths in prostate cancer patients.However, its underlying mechanism is not fully understood. Long noncoding RNAs (lncRNAs) act as crucial regulators in a lot of human cancers, yet their potential roles and molecular mechanisms in CRPC are poorly understood.The goal of this study is to identify the differentially expressed lncRNAs in LNCaP cells and its two castration resistant sublines. more...
Organism:
Homo sapiens
Type:
Non-coding RNA profiling by array
Platform:
GPL20115
3 Samples
Download data: TXT
Series
Accession:
GSE93929
ID:
200093929
8.

Altered expression of genes in HOXD-AS1 knockdown prostate cancer cells

(Submitter supplied) Castration-resistant prostate cancer (CRPC) that arise after the failure of androgen deprivation therapy is a leading cause of deaths in prostate cancer patients. HOXD-AS1 is reported to play a role in bladder cancer and neuroblastoma. However, its function and underlying mechanism in CRPC remains unknown. The goal of this study is to identify the target genes of HOXD-AS1 in prostate cancer. Our results inditcate that the genes regulated by HOXD-S1 involved in a variety of biological functions, such as proliferation and and Androgen Receptor signaling.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL15207
3 Samples
Download data: CEL
Series
Accession:
GSE93928
ID:
200093928
9.

Exploiting Epigenetic Targets to Overcome Taxane Resistance in Prostate Cancer

(Submitter supplied) The development of taxane resistance remains a major challenge for castration resistant prostate cancer (CR-PCa), despite the effectiveness of taxanes in prolonging patient survival. To uncover novel targets, we performed an epigenetic drug screen on taxane (docetaxel and cabazitaxel) resistant CR-PCa cells. We identified BRPF reader proteins, along with several epigenetic groups (CBP/p300, Menin-MLL, PRMT5 and SIRT1) that act as targets effectively reversing the resistance mediated by ABCB1. more...
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing
Platform:
GPL20301
12 Samples
Download data: XLSX
Series
Accession:
GSE247557
ID:
200247557
10.

Docetaxel treatment of sensitve and resistant patients

(Submitter supplied) This SuperSeries is composed of the SubSeries listed below.
Organism:
Homo sapiens
Type:
Expression profiling by array
Dataset:
GDS360
Platform:
GPL8300
24 Samples
Download data: CEL
Series
Accession:
GSE6434
ID:
200006434
11.

Sensitive

(Submitter supplied) These patients were sensitive to docetaxel treatment, exhibiting less than 25% residual tumor. Keywords: repeat sample
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL8300
10 Samples
Download data: CEL
Series
Accession:
GSE350
ID:
200000350
12.

Resistant

(Submitter supplied) These patients proved resistant to docetaxel treatment, exhibiting residual tumor of 25% or greater remaining volume. Keywords: repeat sample
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL8300
14 Samples
Download data: CEL
Series
Accession:
GSE349
ID:
200000349
13.
Full record GDS360

Breast cancer and docetaxel treatment

Breast cancer core biopsies taken from patients found to be resistant (greater than 25% residual tumor volume) or sensitive (less than 25% residual tumor volume) to docetaxel treatment.
Organism:
Homo sapiens
Type:
Expression profiling by array, count, 2 disease state sets
Platform:
GPL8300
Series:
GSE6434
24 Samples
Download data: CEL
DataSet
Accession:
GDS360
ID:
360
14.

Analysis of cabazitaxel-resistant mechanism in human castration-resistant prostate cancer

(Submitter supplied) To investigate cabazitaxel (CBZ) resistance in prostate cancer, we examined the changes in global gene expression before and after development of acquired CBZ resistance. Functional annotation clustering (FAC) analysis of DAVID showed cell division (GO: 0051301) and mitotic nuclear division (GO: 0007067) were the most enhanced clusters in PC3CR compared with PC3.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL570
2 Samples
Download data: CEL
Series
Accession:
GSE182619
ID:
200182619
15.

Single Cell Analysis Reveals NUPR1 Promotes Docetaxel Resistance in Prostate Cancer

(Submitter supplied) The majority of prostate cancer (PCa) patients treated with docetaxel develop resistance to it. In order to better understand the mechanism behind the acquisition of resistance, we conducted single cell total RNA sequencing (sctotal RNA-seq) of docetaxel sensitive and resistant variants of DU145 and PC3 PCa cell lines. Overall, sensitive and resistant cells clustered separately. However, for both cell lines we identified rare sensitive cells that clustered with the resistant cells indicating resistant cells pre-exist in the sensitive population. more...
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing
Platforms:
GPL20301 GPL16791
324 Samples
Download data: TXT
Series
Accession:
GSE140440
ID:
200140440
16.

Regulation of anti-tumorigenic pathways by the combinatory treatment of calcitriol and TGF-β in PC-3 cells

(Submitter supplied) Calcitriol and transforming growth factors beta (TGF-β) are involved in several biological pathways such as cell proliferation, differentiation, migration and invasion. Their cellular effects could be similar or opposite depending on the genetic target, cell type and context. Despite the reported association of calcitriol deficiency and disruption of the TGF-β pathway in prostate cancer and the well-known independent effects of calcitriol and TGF-βs on cancer cells, there is limited information regarding the cellular effects of calcitriol and TGF-β in combination. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL23126
8 Samples
Download data: CEL
Series
Accession:
GSE159116
ID:
200159116
17.

Castration-Resistant Prostate Cancer (CRPC)

(Submitter supplied) Gene expression data from Agilent-014850 4x44K human expression array for CRPC Prostate Cancer study with Xenograph data.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL4133
16 Samples
Download data: TXT
Series
Accession:
GSE33277
ID:
200033277
18.

Transcriptional Analysis of the Effect of Cholinergic Receptor Muscarinic 1 (CHRM1) on Docetaxel Resistance in Human Prostate Cancer Cells

(Submitter supplied) The overall goal of this study was to investigate the role of CHRM1 in contributing to DTX resistance in human prostate cancer cells.
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing
Platform:
GPL24676
6 Samples
Download data: TXT
Series
Accession:
GSE217749
ID:
200217749
19.

Transcriptional patterns associated with OvCar-3 and PC-3 cells in response to osteopontin-c splicing isoform overexpression

(Submitter supplied) This SuperSeries is composed of the SubSeries listed below.
Organism:
Homo sapiens
Type:
Expression profiling by RT-PCR
Platform:
GPL18720
8 Samples
Download data
Series
Accession:
GSE57904
ID:
200057904
20.

Transcriptional patterns associated with PC-3 cells in response to osteopontin-c splicing isoform overexpression

(Submitter supplied) We previously demonstrated that the osteopontin-c (OPNc) splice variant activates several aspects of the progression of prostate cancers. The goal of the present study was to develop cell line model to determine the impact of OPNc overexpression on main cancer signaling pathways and thus obtain insights into the mechanisms of OPNc pro-tumorigenic roles. Methods: PC-3 cells were stably transfected to overexpress OPNc. more...
Organism:
Homo sapiens
Type:
Expression profiling by RT-PCR
Platform:
GPL18720
4 Samples
Download data: TXT
Series
Accession:
GSE57889
ID:
200057889
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

db=gds|term=|query=1|qty=2|blobid=MCID_675373a99892923b3c1a923c|ismultiple=true|min_list=5|max_list=20|def_tree=20|def_list=|def_view=|url=/Taxonomy/backend/subset.cgi?|trace_url=/stat?
   Taxonomic Groups  [List]
Tree placeholder
    Top Organisms  [Tree]

Find related data

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center